Auro Laboratories Limited (BOM:530233)
298.65
-0.90 (-0.30%)
At close: Feb 12, 2026
Auro Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 0 | 9.92 | 17.87 | 52.12 | 108.21 |
Short-Term Investments | - | - | - | - | 71.84 | - |
Cash & Short-Term Investments | 6.65 | 0 | 9.92 | 17.87 | 123.96 | 108.21 |
Cash Growth | -4.24% | -99.97% | -44.48% | -85.58% | 14.55% | 114.94% |
Accounts Receivable | - | 93.93 | 133.92 | 124.05 | 136.13 | 72.99 |
Other Receivables | - | 46.25 | 57.33 | 51.18 | 32.29 | 28.82 |
Receivables | - | 140.19 | 191.25 | 175.23 | 168.42 | 101.81 |
Inventory | - | 36.68 | 82.4 | 117.56 | 42.55 | 25.47 |
Prepaid Expenses | - | 6.8 | 7.3 | 8.21 | 16.38 | 6.86 |
Other Current Assets | - | 31.47 | 17.67 | 37.76 | 24.98 | 39.18 |
Total Current Assets | - | 215.14 | 308.53 | 356.62 | 376.28 | 281.53 |
Property, Plant & Equipment | - | 775.34 | 548.31 | 202.83 | 172.83 | 136.91 |
Long-Term Investments | - | 0.49 | 0.49 | 0.49 | 0.49 | 0.49 |
Other Long-Term Assets | - | - | -0 | 0 | 0 | - |
Total Assets | - | 990.96 | 857.33 | 559.94 | 549.6 | 418.93 |
Accounts Payable | - | 62.13 | 62.05 | 114.8 | 48.62 | 57.5 |
Accrued Expenses | - | 8.49 | 14.23 | 11.89 | 15.56 | 16.54 |
Short-Term Debt | - | 103.9 | 77.98 | 42.56 | 117.88 | 6.6 |
Current Portion of Long-Term Debt | - | 15.39 | 0.68 | 1.44 | 3.27 | 1.08 |
Current Income Taxes Payable | - | 1.03 | 27.41 | 10.01 | 10.67 | 9.32 |
Other Current Liabilities | - | 25.47 | 57 | 0.61 | 5.3 | 1.31 |
Total Current Liabilities | - | 216.42 | 239.35 | 181.31 | 201.31 | 92.36 |
Long-Term Debt | - | 307.85 | 183.78 | 20.13 | 16.62 | 23.9 |
Long-Term Deferred Tax Liabilities | - | 14.01 | 14.62 | 16.49 | 16.47 | 16.84 |
Other Long-Term Liabilities | - | 23 | -0 | - | - | - |
Total Liabilities | - | 561.28 | 437.75 | 217.94 | 234.39 | 133.1 |
Common Stock | - | 62.33 | 62.33 | 62.33 | 62.33 | 62.33 |
Additional Paid-In Capital | - | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 |
Retained Earnings | - | 360.68 | 350.59 | 273.01 | 246.21 | 216.83 |
Comprehensive Income & Other | - | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 |
Shareholders' Equity | 435.78 | 429.68 | 419.59 | 342.01 | 315.21 | 285.83 |
Total Liabilities & Equity | - | 990.96 | 857.33 | 559.94 | 549.6 | 418.93 |
Total Debt | 439.43 | 427.14 | 262.44 | 64.13 | 137.78 | 31.59 |
Net Cash (Debt) | -432.78 | -427.14 | -252.52 | -46.26 | -13.82 | 76.63 |
Net Cash Growth | - | - | - | - | - | 307.89% |
Net Cash Per Share | -69.55 | -68.53 | -40.52 | -7.42 | -2.22 | 12.29 |
Filing Date Shares Outstanding | 6.24 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
Total Common Shares Outstanding | 6.24 | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
Working Capital | - | -1.28 | 69.19 | 175.31 | 174.98 | 189.18 |
Book Value Per Share | 70.01 | 68.94 | 67.32 | 54.87 | 50.58 | 45.86 |
Tangible Book Value | 435.78 | 429.68 | 419.59 | 342.01 | 315.21 | 285.83 |
Tangible Book Value Per Share | 70.01 | 68.94 | 67.32 | 54.87 | 50.58 | 45.86 |
Land | - | 103.19 | 103.19 | 0.44 | 0.44 | 0.44 |
Buildings | - | 43.05 | 43.05 | 43.05 | 43.05 | 43.05 |
Machinery | - | 212.91 | 212.87 | 209.34 | 208.62 | 197.93 |
Construction In Progress | - | 564.75 | 326.81 | 76.68 | 36.75 | 1.34 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.